PHILADELPHIA, July 30, 2022 (GLOBE NEWSWIRE) — Kaskela Law LLC announces that it is investigating Hanger, Inc. (“Hanger”) HNGR on behalf of the shareholders of the company.

On July 21, 2022, Hanger announced that it had agreed to an acquisition by private investment firm Patient Square Capital at a price of $18.75 per share (The buying price”). Upon completion of the proposed transaction, HNGR shareholders will be cashed out of their investment position and the Company’s shares will no longer be publicly traded. Notably, Hanger’s common stock was still trading above the buyout price as recently as April 2022.

The investigation is designed to determine whether the buyout price provides Hanger investors with adequate financial consideration for their shares and whether Hanger officers/directors violated securities laws or their fiduciary duties in selling the company to Patient Square Capital.

Hanger shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (888) 715-1740 or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/hanger-inc/ for more information about this investigation and your legal rights and choices.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance and merger and acquisition litigation and has helped recover more than $100 million on behalf of aggrieved investors. For more information about Kaskela Law LLC, visit www.kaskelalaw.com.

CONTACT:

D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 229-0750
(888) 715-1740
www.kaskelalaw.com

This notice may constitute attorney solicitation in certain jurisdictions.